210 related articles for article (PubMed ID: 29844128)
1. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with
Peters TL; Tillotson J; Yeomans AM; Wilmore S; Lemm E; Jiménez-Romero C; Amador LA; Li L; Amin AD; Pongtornpipat P; Zerio CJ; Ambrose AJ; Paine-Murrieta G; Greninger P; Vega F; Benes CH; Packham G; Rodríguez AD; Chapman E; Schatz JH
Clin Cancer Res; 2018 Sep; 24(17):4256-4270. PubMed ID: 29844128
[No Abstract] [Full Text] [Related]
2. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E
Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063
[TBL] [Abstract][Full Text] [Related]
3. Plakophilin 1 stimulates translation by promoting eIF4A1 activity.
Wolf A; Krause-Gruszczynska M; Birkenmeier O; Ostareck-Lederer A; Hüttelmaier S; Hatzfeld M
J Cell Biol; 2010 Feb; 188(4):463-71. PubMed ID: 20156963
[TBL] [Abstract][Full Text] [Related]
4. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
6. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
[TBL] [Abstract][Full Text] [Related]
7. Understanding the thermal response of rice eukaryotic transcription factor
Singha DL; Maharana J; Panda D; Dehury B; Modi MK; Singh S
J Biomol Struct Dyn; 2021 Apr; 39(7):2575-2584. PubMed ID: 32367760
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regions.
Steinberger J; Shen L; J Kiniry S; Naineni SK; Cencic R; Amiri M; Aboushawareb SAE; Chu J; Maïga RI; Yachnin BJ; Robert F; Sonenberg N; Baranov PV; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(17):9521-9537. PubMed ID: 32766783
[TBL] [Abstract][Full Text] [Related]
9. mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3
Jiao D; Sun H; Zhao X; Chen Y; Lv Z; Shi Q; Li Y; Wang C; Gao K
Elife; 2024 May; 12():. PubMed ID: 38738857
[TBL] [Abstract][Full Text] [Related]
10. eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
Steinmann SM; Sánchez-Martín A; Tanzer E; Cigliano A; Pes GM; Simile MM; Desaubry L; Marin JJG; Evert M; Calvisi DF
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768380
[TBL] [Abstract][Full Text] [Related]
11. Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.
Ernst JT; Thompson PA; Nilewski C; Sprengeler PA; Sperry S; Packard G; Michels T; Xiang A; Tran C; Wegerski CJ; Eam B; Young NP; Fish S; Chen J; Howard H; Staunton J; Molter J; Clarine J; Nevarez A; Chiang GG; Appleman JR; Webster KR; Reich SH
J Med Chem; 2020 Jun; 63(11):5879-5955. PubMed ID: 32470302
[TBL] [Abstract][Full Text] [Related]
12. The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis.
Pause A; Méthot N; Sonenberg N
Mol Cell Biol; 1993 Nov; 13(11):6789-98. PubMed ID: 8413273
[TBL] [Abstract][Full Text] [Related]
13. The steroid derivative 6-aminocholestanol inhibits the DEAD-box helicase eIF4A (LieIF4A) from the Trypanosomatid parasite Leishmania by perturbing the RNA and ATP binding sites.
Abdelkrim YZ; Harigua-Souiai E; Barhoumi M; Banroques J; Blondel A; Guizani I; Tanner NK
Mol Biochem Parasitol; 2018 Dec; 226():9-19. PubMed ID: 30365976
[TBL] [Abstract][Full Text] [Related]
14. Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.
Kayastha F; Herrington NB; Kapadia B; Roychowdhury A; Nanaji N; Kellogg GE; Gartenhaus RB
Mol Med; 2022 Sep; 28(1):101. PubMed ID: 36058921
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumour effects of elatol, a marine derivative compound obtained from red algae Laurencia microcladia.
Campos A; Souza CB; Lhullier C; Falkenberg M; Schenkel EP; Ribeiro-do-Valle RM; Siqueira JM
J Pharm Pharmacol; 2012 Aug; 64(8):1146-54. PubMed ID: 22775218
[TBL] [Abstract][Full Text] [Related]
16. RNA helicase EIF4A1-mediated translation is essential for the GC response.
Screen M; Matheson LS; Howden AJ; Strathdee D; Willis AE; Bushell M; Sansom O; Turner M
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38011999
[TBL] [Abstract][Full Text] [Related]
17. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
[TBL] [Abstract][Full Text] [Related]
18. eIF4A RNA Helicase Associates with Cyclin-Dependent Protein Kinase A in Proliferating Cells and Is Modulated by Phosphorylation.
Bush MS; Pierrat O; Nibau C; Mikitova V; Zheng T; Corke FM; Vlachonasios K; Mayberry LK; Browning KS; Doonan JH
Plant Physiol; 2016 Sep; 172(1):128-40. PubMed ID: 27388680
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA).
Kommaraju SS; Aulicino J; Gobbooru S; Li J; Zhu M; Romo D; Low WK
Biochem Cell Biol; 2020 Aug; 98(4):502-510. PubMed ID: 32008367
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
Wang C; Leavenworth J; Zhang C; Liu Z; Yuan KY; Wang Y; Zhang G; Wang S; Cui X; Zhang Y; Bae S; Zhou J; Wang L; Liu R
Oncogene; 2022 May; 41(19):2778-2785. PubMed ID: 35361883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
